4.7 Review

Roles of microRNA on cancer cell metabolism

Journal

JOURNAL OF TRANSLATIONAL MEDICINE
Volume 10, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1479-5876-10-228

Keywords

MicroRNA; Cell metabolism; MiRNA biomarker

Funding

  1. National Key Basic Research Program of China [2011CB910703, 2013CB911303]
  2. National Natural Sciences Foundation of China [30970654, 31071235]
  3. grants for New Century Excellent Talents in University [NCET-10-0595]
  4. specialized research fund for the Doctoral Program of Higher Education [20120181110025]
  5. Sichuan Province Program [2010JQ0016, 2012SZ0002]
  6. Chengdu Local Scientific Project [11DXYB356JH-027]

Ask authors/readers for more resources

Advanced studies of microRNAs (miRNAs) have revealed their manifold biological functions, including control of cell proliferation, cell cycle and cell death. However, it seems that their roles as key regulators of metabolism have drawn more and more attention in the recent years. Cancer cells display increased metabolic autonomy in comparison to non-transformed cells, taking up nutrients and metabolizing them in pathways that support growth and proliferation. MiRNAs regulate cell metabolic processes through complicated mechanisms, including directly targeting key enzymes or transporters of metabolic processes and regulating transcription factors, oncogenes / tumor suppressors as well as multiple oncogenic signaling pathways. MiRNAs like miR-375, miR-143, miR-14 and miR-29b participate in controlling cancer cell metabolism by regulating the expression of genes whose protein products either directly regulate metabolic machinery or indirectly modulate the expression of metabolic enzymes, serving as master regulators, which will hopefully lead to a new therapeutic strategy for malignant cancer. This review focuses on miRNA regulations of cancer cell metabolism, including glucose uptake, glycolysis, tricarboxylic acid cycle and insulin production, lipid metabolism and amino acid biogenesis, as well as several oncogenic signaling pathways. Furthermore, the challenges of miRNA-based strategies for cancer diagnosis, prognosis and therapeutics have been discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available